Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

 

Current Issue

November-December 2025 (Vol. 39 Issue 6) Table of Contents
In Vivo: 39 (6)

Issue highlights

  • Comparative Evaluation of Biocompatibility Data from the Subcutaneous and the Calvaria Implantation Model of a Novel Bone Substitute Block
  • Prognostic Role of Bacterial Translocation, Serum Endotoxin, and ZO-1 in Postoperative Infections Following Colorectal Cancer Surgery
  • Adipose-derived Stem Cell Sheets Induce Angiogenesis and Hepatic Stellate Cell Activation
  • Epidemiological Profile of Hepatocellular Carcinoma in Brazil
  • Gene Profiling Analyses of Synovium Tissues in Korean Osteoarthritis Patients

 


 

Two Special Issues are coming in 2025:

  1. Diabetes: New Antidiabetic Agents; Stem Cell Therapy; Pancreas Transplantation  – 2025 (Submission deadline: September 30, 2025; Publication date: January 2026). ​Click here for more information. 
  2. "In Vivo, In Vitro and In Silico Characterization of Permanent and Biodegradable Implants" is now published and you may find it here.

Featured Articles

  • Coronavirus Disease (COVID-19): A Machine Learning Bibliometric Analysis
    June 05, 2020
  • Curcumin Suppression of Cytokine Release and Cytokine Storm. A Potential Therapy for Patients with...
    January 19, 2015
  • Anti-inflammatory Activity of β-Carotene, Lycopene and Tri-n-butylborane, a Scavenger of...
    February 23, 2018
  • Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving...
    April 25, 2018
  • Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process
    June 05, 2020

Latest Articles

  • Open Access
    Integrated Multimodal Approaches in Pediatric Palliative Oncology: A Systematic Review Focused on Infants and Toddlers
    ANGELA PRENDIN, MARTINA COSTA, GLORIA ANGELA BARACCO, VINCENZO ANDRETTA, MARCO CASCELLA, MARIA ROSARIA MUZIO, SABRINA BIMONTE, FERDINANDO SPAGNUOLO and VALENTINA CERRONE
    In Vivo November 2025, 39 (6) 3082-3089; DOI: https://doi.org/10.21873/invivo.14110
  • Open Access
    Impact of Cyclin-dependent Kinase Inhibitor 1A Genotypes on Prostate Cancer Susceptibility Prediction
    CHENG-HSI LIAO, DA-TIAN BAU, BO-REN WANG, SHU-YU CHANG, TE-CHUN HSIA, HSU-TUNG LEE, JAW-CHYUN CHEN, WEN-CHIN HUANG, CHIA-WEN TSAI, YUN-CHI WANG, HOU-YU SHIH and WEN-SHIN CHANG
    In Vivo November 2025, 39 (6) 3184-3194; DOI: https://doi.org/10.21873/invivo.14118
  • Open Access
    Comparison of Survival Outcomes and Toxicities Between Volumetric-modulated Arc Therapy and Conventional Radiotherapy in Early Glottic Cancer
    HYEON KANG KOH, YOUNGHEE PARK, TAERYOOL KOO, KWANG-HO CHEONG, ME YEON LEE, HAE JIN PARK, KYOUNG JU KIM, SOAH PARK, TAEJIN HAN, SEI-KWON KANG, BORAM HA, JAI-WOONG YOON, ME YOUNG KIM and HOONSIK BAE
    In Vivo November 2025, 39 (6) 3529-3538; DOI: https://doi.org/10.21873/invivo.14151
  • Open Access
    Disproportionality Analysis of Gastrointestinal Adverse Events Associated With Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report database
    YUKO KANBAYASHI, RISA MORIOKA, KOICHI TAKAYAMA and KEIKO HOSOHATA
    In Vivo November 2025, 39 (6) 3453-3460; DOI: https://doi.org/10.21873/invivo.14143
  • Open Access
    Impact of Multiple Primary Cancers on the Prognosis of Early-stage Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma: A Single-center Retrospective Study
    RYUJI YASUMATSU, DAISUKE ABE, TAKAYUKI KIMURA, SHINICHIRO IWATA, MASAYUKI OCHIAI, SAYUMI KONYA, MAYA KAWAMOTO, MASAHIRO UMEMOTO, SATORU KOIKE, MITSUO SATO, MUTSUKAZU KITANO and TAKAHIRO WAKASAKI
    In Vivo November 2025, 39 (6) 3581-3588; DOI: https://doi.org/10.21873/invivo.14156
  • Open Access
    Preoperative Liver Function as a Predictor of Postoperative Liver Failure in Perihilar Cholangiocarcinoma
    YASUNORI YOSHIMI, SATOKO YORINAGA, TAKEHIRO NOJI, SHINTARO TAKEUCHI, MASATAKA WADA, KIMITAKA TANAKA, AYA MATSUI, YOSHITSUGU NAKANISHI, TOSHIMICHI ASANO and SATOSHI HIRANO
    In Vivo November 2025, 39 (6) 3491-3502; DOI: https://doi.org/10.21873/invivo.14147
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks
The Antitumor Activities of Flavonoids
Melanoma: Epidemiology, Risk Factors, Pathogenesis, Diagnosis and Classification
Muscle Regeneration: Cellular and Molecular Events
Radioprotection
Intraarterial Hepatic Chemoembolization of Liver Metastases from Colorectal Cancer Adopting Irinotecan-eluting Beads: Results of a Phase II Clinical Study
Visit the official website of In Vivo.
 
Back to top
In Vivo

© 2025 In Vivo

Powered by HighWire